Biogen Idec Inc. chief executive George Scangos was skeptical when he learned company researchers were pursuing a new treatment for Lou Gehrig’s disease.
|
Scooped by
TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
onto #ALS AWARENESS #LouGehrigsDisease #PARKINSONS April 4, 2012 5:12 PM
|